4.5 Article

Inhaled hydrogen sulfide improves graft function in an experimental model of lung transplantation

Journal

JOURNAL OF SURGICAL RESEARCH
Volume 178, Issue 2, Pages 593-600

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jss.2012.06.037

Keywords

Transplantation, lung; Ischemia/reperfusion injury, lung; Animal model; Hydrogen sulfide

Categories

Funding

  1. Thoracic Surgery Foundation for Research and Education [90038390]
  2. National Institutes of Health [T32 2T32DK007713-12]

Ask authors/readers for more resources

Objectives: Ischemia/reperfusion injury (IRI) is a common complication of lung transplantation (LTx). Hydrogen sulfide (H2S) is a novel agent previously shown to slow metabolism and scavenge reactive oxygen species, potentially mitigating IRI. We hypothesized that pretreatment with inhaled H2S would improve graft function in an ex vivo model of LTx. Methods: Rabbits (n = 10) were ventilated for 2 h prior to heart-lung bloc procurement. The treatment group (n = 5) inhaled room air (21% O-2) supplemented with 150 ppm H2S while the control group (n = 5) inhaled room air alone. Both groups were gradually cooled to 34 degrees C. All heart-lung blocs were then recovered and cold-stored in low-potassium dextran solution for 18 h. Following storage, the blocs were reperfused with donor rabbit blood in an ex vivo apparatus. Serial clinical parameters were assessed and serial tissue biochemistry was examined. Results: Prior to heart-lung bloc procurement, rabbits pretreated with H2S exhibited similar oxygenation (P = 0.1), ventilation (P = 0.7), and heart rate (P = 0.5); however, treated rabbits exhibited consistently higher mean arterial blood pressures (P = 0.01). During reperfusion, lungs pretreated with H2S had better oxygenation (P < 0.01) and ventilation (P = 0.02), as well as lower pulmonary artery pressures (P < 0.01). Reactive oxygen species levels were lower in treated lungs during reperfusion (P = 0.01). Additionally, prior to reperfusion, treated lungs demonstrated more preserved mitochondrial cytochrome c oxidase activity (P = 0.01). Conclusions: To our knowledge, this study represents the first reported therapeutic use of inhaled H2S in an experimental model of LTx. After prolonged ischemia, lungs pretreated with inhaled H2S exhibited improved graft function during reperfusion. Donor pretreatment with inhaled H2S represents a potentially novel adjunct to conventional preservation techniques and merits further exploration. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available